KARDİYOVASKÜLER HASTALIKLAR VE EKONOMİK BÜYÜME: BİBLİYOMETRİK VERİLERLE BİR DEĞERLENDİRME

Abstract

Giriş: Bu çalışma, sağlık ve ekonomi kesişiminde yer alan bilimsel yayınların küresel düzeydeki dağılımını, konu başlıklarını, yöntemsel eğilimlerini ve atıf etkilerini analiz etmek amacıyla Web of Science (WoS) veritabanında taranan 86 yayını bibliyometrik yöntemlerle incelemektedir. Yöntem: Web of Science veri tabanında "gdp AND cardiovascular diseases AND burden of diseases" anahtar kelimeleriyle yapılan tarama sonucunda ilgili akademik yayınlar belirlenmiştir.Elde edilen veriler, bibliyometrik analiz yöntemiyle incelenmiştir. Bu analiz, yayınların yıllara göre dağılımı, en çok atıf alan yazarlar, en sık kullanılan anahtar kelimeler ve en üretken kurumlar gibi kriterleri içermektedir. Analiz sonuçları, VOSviewer yazılımı kullanılarak görselleştirilmiştir. Bulgular: Bu çalışma, sağlık ve ekonomi kesişiminde yer alan bilimsel yayınların küresel düzeydeki dağılımını, konu başlıklarını, yöntemsel eğilimlerini ve atıf etkilerini analiz etmek amacıyla Web of Science (WoS) veritabanında taranan 86 yayını bibliyometrik yöntemlerle incelemektedir. İncelenen yayınların büyük çoğunluğunun İngilizce (%91,8) ve araştırma makalesi (%94,2) olduğu, sağlık ve çevre temalarının ön planda bulunduğu belirlenmiştir. "Public, Environmental & Occupational Health" kategorisi %35,6 ile en yoğun alan olarak öne çıkarken, bunu kardiyovasküler sistemler, çevre bilimleri ve sağlık hizmetleri takip etmektedir. Yayınların coğrafi dağılımında Birleşik Krallık, ABD ve Rusya başı çekerken; atıf analizleri, yayınların akademik etkisinin yüksek olduğunu (ortalama 33,0 atıf) göstermektedir. Araştırmalarda ağırlıklı olarak ekonometrik modellemeler, mekânsal analizler, maliyet-etkinlik çalışmaları, DALY, YLL gibi ölçütler kullanılmıştır. Konu bazında kardiyovasküler hastalıklar, diyabet, kanser ve bulaşıcı hastalıklar öne çıkarken; risk faktörleri arasında obezite, sigara, fiziksel aktivite eksikliği ve çevresel maruziyetler dikkat çekmektedir. Yayınların %85’inin son on yılda yapılmış olması, bu alana yönelik bilimsel ilginin hızla arttığını ortaya koymakta; özellikle pandemi sonrası süreçte sağlık ekonomisi, sürdürülebilir kalkınma ve sosyoekonomik belirleyiciler gibi konuların uluslararası düzeyde daha çok araştırıldığını göstermektedir. Bu eğilimler, disiplinler arası çalışmaların önemini artırmakta ve sağlık politikalarına yönelik bilimsel katkıyı güçlendirmektedir. Sonuç: Analiz edilen yayınlar, çevre ve halk sağlığı konularının ön planda olduğunu, ancak sağlıkla ilgili diğer disiplinlerin de önemli katkılar sağladığını ortaya koymaktadır. Bu durum, sağlık araştırmalarının çok disiplinli bir yaklaşım gerektirdiğini ve farklı alanlar arasındaki iş birliğinin önemini vurgulamaktadır.

Keywords

• Sağlık Ekonomisi
• Bibliyometrik Analiz
• Kardiyovasküler Hastalıklar
• Hastalık Yükü
• Çevresel Faktörler
• Web of Science

CARDIOVASCULAR DISEASES AND ECONOMIC GROWTH: AN EVALUATION WITH BIBLIOMETRIC DATA

Abstract

Introduction: This study aims to analyze the global distribution, thematic focus, methodological trends, and citation impact of scientific publications situated at the intersection of health and economics. A total of 86 publications retrieved from the Web of Science (WoS) database were examined using bibliometric methods. Method: Relevant academic publications were identified by searching the Web of Science database using the keywords “gdp AND cardiovascular diseases AND burden of diseases.” The data obtained were examined using bibliometric analysis methods. This analysis included criteria such as the distribution of publications by year, the most cited authors, the most frequently used keywords, and the most productive institutions. The analysis results were visualised using VOSviewer software. Findings: The vast majority of the analyzed publications were in English (91.8%) and consisted of original research articles (94.2%). Thematic analysis revealed a strong emphasis on health and environmental topics. The category "Public, Environmental & Occupational Health" accounted for 35.6% of the publications, followed by cardiovascular systems, environmental sciences, and health care services. Geographically, the United Kingdom, the United States, and Russia were the leading contributors. Citation analysis revealed a high academic impact, with an average of 33.0 citations per publication. The studies primarily employed econometric modeling, spatial analysis, cost-effectiveness analyses, and indicators such as DALY, YLL. The most frequently addressed diseases included cardiovascular diseases, diabetes, cancer, and infectious diseases, while major risk factors identified were obesity, smoking, physical inactivity, and environmental exposures. A significant increase in publication volume was observed in the past decade (85% of the studies), indicating a growing scientific interest in this field—particularly in the post-pandemic era. Topics such as health economics, sustainable development, and social determinants of health have gained international attention. These trends underscore the rising importance of interdisciplinary research and its contribution to health policy development Conclusion: The analyzed publications demonstrate that environmental and public health topics are highly prominent, while other health-related disciplines also provide substantial contributions. This indicates that health research requires a multidisciplinary approach and highlights the importance of collaboration across diverse fields.

Keywords

• Health economics
• Bibliometric analysis
• Cardiovascular diseases
• Burden of Disease
• Environmental factors
• Web of Science.

References

1. Abushanab, D; Al-Badriyeh, D; Marquina, C; Morton, J; Lloyd, M; Zomer, E; Talic, S; Liew, D; Ademi, Z. (2024). The Reduction Of The Productivity Burden Of Cardiovascular Disease By Improving The Risk Factor Control Among Australians With Type 2 Diabetes: A 10-Year Dynamic Analysis. European Journal Of Preventive Cardiology, doi:10.1093/eurjpc/zwae292.
2. *Ademi, Z; Marquina, C; Zomer, E; Bailey, C; Owen, A; Pang, J; Norman, R; Watts, GF; Liew, D. (2020). The Economic Impact Of Familial Hypercholesterolemia On Productivity. Journal Of Clınıcal Lipidology, 14(6):799+. doi:10.1016/j.jacl.2020.08.004.
3. *Ali, SS; Mishra, PK. (2013). Management Strategies For Treatment Of Cardiovascular Diseases İn India: A Review. Bioscience Biotechnology Research Communications,6(2):170-173.
4. *Ajayi, AA; Sofowora, GG; Ladipo, GO. (2020). Explaining Heart Failure Hyper-mortality in Sub Saharan Africa: Global Genomic and Environmental Contribution Review. Journal Of The National Medical Association, 112(2):141-157. doi: 10.1016/j.jnma.2020.02.003.
5. *Balanova, YA; Kontsevaya, AV; Imaeva, AE; Karpov, OI; Khudyakov, MB. (2018). Economic Losses Due To Low Coverage Of Lipid-Lowering Therapy İn Patients With Cardiovascular Diseases İn The Russian Federation, Rational Pharmacotherapy In Cardiology, 14(5):716-724. doi:10.20996/1819-6446-2018-14-5-716-724.
6. *Balanova, YA; Kontsevaya, AV; Myrzamatova, AO; Mukaneeva, DK; Khudyakov, MB; Drapkina, OM (2020). Economic Burden of Hypertension in the Russian Federation. Rational Pharmacotherapy In Cardiology,16 (3): 415-423. doi: 10.20996/1819-6446-2020-05-03.
7. *Baptista, EA; Queiroz, BL.(2019).The Relation Between Cardiovascular Mortality And Development: A Study Of Small Areas in Brazil, 2001-2015. Demographıc Research, 41:1437-1452. doi: 10.4054/DemRes.2019.41.51
8. Baptista, EA; Kakinuma, K; Queiroz, BL.(2020). Association between Cardiovascular Mortality and Economic Development: A Spatio-Temporal Study for Prefectures in Japan. International Journal Of Environmental Research And Public Health,17(4), 1311; https://doi.org/10.3390/ijerph17041311.

9. Baptista, EA; Queiroz, BL. (2022). Spatial Analysis Of Cardiovascular Mortality And Associated Factors Around The World. BMC Public Health, 22(1), 10.1186/s12889-022-13955-7.
10. Bloom, D.E., Cafiero-Fonseca, E.T., McGovern, M.E., Prettner, K., Stanciole, A., Weiss, J., Bakkila, S., ve Rosenberg, L. (2014). The Macroeconomic İmpact Of Non-Communicable Diseases İn China And India: Estimates, Projections, And Comparisons. The Journal of the Economics of Ageing, 4, 100-111. https://doi.org/10.1016/j.jeoa.2014.08.003
11. *Bloom, DE; Chen, SM; McGovern, ME. (2018). The Economic Burden Of Noncommunicable Diseases And Mental Health Conditions: Results For Costa Rica, Jamaica, And Peru. Revısta Panamericana De Salud Publica-Pan American Journal Of Public Health, 42, 10.26633/RPSP.2018.18.
12. *Bloom, DE; Chen, SM; Kuhn, M; McGovern, ME; Oxley, L; Prettner, K. (2020). The Economic Burden Of Chronic Diseases: Estimates And Projections For China, Japan, And South Korea. Journal Of The Economics Of Ageing, 17. https://doi.org/10.1016/j.jeoa.2018.09.002.
13. *Boachie, MK; Thsehla, E; Immurana, M; Kohli-Lynch, C; Hofman, KJ. (2022). Estimating The Healthcare Cost Of Overweight And Obesity İn South Africa. Global Health Action, 15(1), 10.1080/16549716.2022.2045092.
14. Bollyky, TJ; Templin, T; Cohen, M; Schoder, D; Dieleman, JL; Wigley, S. (2019). The Relationships Between Democratic Experience, Adult Health, And Cause-Specific Mortality İn 170 Countries Between 1980 And 2016: An Observational Analysis. Lancet,393(10181):1628-1640. doi:10.1016/S0140-6736(19)30235-1
15. *Cavalcante, DDB; Brizon, VSC; Probst, LF; Meneghim, MD; Pereira, AC; Ambrosano, GMB.(2018). Did The Family Health Strategy Have An Impact On İndicators Of Hospitalizations For Stroke And Heart Failure? Longitudinal Study in Brazil: 1998-2013. PLOS ONE,13(6), 10.1371/journal.pone.0198428.
16. Carter HE, Schofield D, Shrestha R (2019). Productivity Costs Of Cardiovascular Disease Mortality Across Disease Types And Socioeco-Nomic Groups. Open Heart,6(1):e000939. doi:10.1136/openhrt-2018-00093 Çetin, M, Ecevit E. (2010). Sağlık Harcamalarının Ekonomik Büyüme Üzerindeki Etkisi: OECD Ülkeleri Üzerine Bir Panel Regresyon Analizi, Doğuş Üniversitesi Dergisi, 11(2): 166-182.
17. *Chazova, IE; Martynyuk, TV; Valieva, ZS; Nakonechnikov, SN; Nedogoda, SV; Salasyuk, AS; Taran, IN; Gratsianskaya, SE. (2018). The Economic Burden Of Chronic Thromboembolic Pulmonary Hypertension In Russian Federation. Terapevtıcheskıı Arkhıv., 90(9):101-109. doi: 10.26442/terarkh2018909101-109.
18. *Chen, L; Mao, J; Shi, MS; Zhang, H; Sun, YL; Gao, S; Li, SH; Li, MY; Ma, ZX; Bai, ZP. (2018). Estimating Short-Term Mortality And Economic Benefit Attributable To PM10 Exposure In China Based On Benmap. Environmental Science And Pollution Research, 25(28): 28367-28377 http://dx.doi.org/10.1007/s11356-018-2805-5
19. Chirikov, VV; Walker, C; Stephens, JM; Schepman, P; Chambers, R; Bakir, M; Poorman, GW; Haider, S; Farghaly, M. (2021). Evaluating the Cost-Effectiveness of Celecoxib versus Ibuprofen and Naproxen in Patients with Osteoarthritis in United Arab Emirates Based on the PRECISION Trial. Clinicoeconomics And Outcomes Research, 13, 409-420. doi:10.2147/CEOR.S280556.
20. *Dandona, L; Dandona, R; Kumar, GA; Cowling, K; Titus, P; Katoch, VM; Swaminathan, S. (2017). Mapping Of Health Research Funding In India. National Medical Journal Of India,30(6):309-316. doi:10.4103/0970-258X.239069
21. *Darba, S; Safaei, N; Mahboub-Ahari, A; Nosratnejad, S; Alizadeh, G; Ameri, H; Yousefi, M. (2020). Direct and Indirect Costs Associated with Coronary Artery (Heart) Disease in Tabriz, Iran. Risk Management And Healthcare Policy, 13,969-978. doi:10.2147/RMHP.S261612.
22. *Dedov, II; Kontsevaya, AV; Shestakova, MV; Belousov, YB; Balanova, JA; Khudyakov, MB; Karpov, OI. (2016). Economic Evaluation Of Type 2 Diabetes Mellitus Burden And Its Main Cardiovascular Complications In The Russian Federation. Diabetes Mellitus, 19(6):518-527. doi:10.14341/DM8153.
23. *Do, LA; Synnott, PG; Ma, SY; Ollendorf, DA. (2021). Bridging The Gap: Aligning Economic Research With Disease Burden. BMJ Global Health, 6(6): 10.1136/bmjgh-2021-005673.
24. *Dong, YH; Ma, YH; Hu, PJ; Dong, B; Zou, ZY; Yang, YD; Xu, RB; Wang, ZH; Yang, ZG; Wen, B; Tan, M; He, FJ; Song, Y; Ma, J; Sawyer, SM; Patton, GC. (2020). Ethnicity, Socioeconomic Status And The Nutritional Status Of Chinese Children And Adolescents: Findings From Three Consecutive National Surveys Between 2005 And 2014. Pediatric Obesity, 15(11), 10.1111/ijpo.12664.
25. *Dong, XY; He, XN; Wu, J. (2022). Cost Effectiveness of the First-in-Class ARNI (Sacubitril/Valsartan) for the Treatment of Essential Hypertension in a Chinese Setting. Pharmacoeconomıcs, 40(12):1187-1205. doi: 10.1007/s40273-022-01182-2.
26. DSÖ (2025). https://www.who.int/health-topics/cardiovascular-diseases#tab=tab1 *Ekinci, G. (2023). Economic Impacts of Cardiovascular Diseases: An Econometric Evaluation in Turkey. Iranian Journal Of Public Health, 52(1):118-127.
27. Ekinci, G. (2024). Evaluation Of Long-Term Care Expenditures From The Silver Economy Perspective. Global Health Econ Sustain.https://doi.org/10.36922/ghes.3298.
28. *Espinola, N; Pichon-Riviere, A; Casarini, A; Alcaraz, A; Bardach, A; Williams, C; Cairoli, FR; Augustovski, F; Palacios, A. (2023). Making Visible The Cost Of İnformal Caregivers' Time In Latin America: A Case Study For Major Cardiovascular, Cancer And Respiratory Diseases In Eight Countries. BMC Publıc Health,23(1), 10.1186/s12889-022-14835-w.
29. Feigl, AB; Goryakin, Y; Devaux, M; Lerouge, A; Vuik, S; Cecchini, M. (2019). The Short-Term Effect Of BMI, Alcohol Use, And Related Chronic Conditions On Labour Market Outcomes: A Time-Lag Panel Analysis Utilizing European SHARE dataset. PLOS ONE, 14(3), 10.1371/journal.pone.0211940.
30. *Fray-Aiken, CM; Wilks, RJ; Abdulkadri, AO; McCaw-Binns, AM. (2016). Cost Of Care Of Chronic Non-Communicable Diseases In Jamaican Patients: The Role Of Obesity. Farmeconomia-Health Economics And Therapeutic Pathways, 17(2):81-95. doi: 10.7175/fe.v17i2.1232.
31. *Gao, AF; Wang, JY; Poetzscher, J; Li, SR; Gao, BY; Wang, P; Luo, JF; Fang, XF; Li, JY; Hu, JL; Gao, JS; Zhang, HL. (2022). Coordinated Health Effects Attributable To Particulate Matter And Other Pollutants Exposures In The North China Plain. Environmental Research, 208, 10.1016/j.envres.2021.112671.
32. *Gasca-Pineda, R; Osorio-Hernández, M; Mehta, R; Escobedo-de-la-Peña, J; Narváez-Oriani, CA. (2023). Economic Burden Of Hypercholesterolemia In High Risk Of Cardiovascular Disease Population In Mexico. Archivos De Cardiologia De Mexico, 93(3): 328-335. doi: 10.24875/ACM.22000195.
33. *Golubnitschaja, O; Potuznik, P; Polivka, J, Jr; Pesta, M; Kaverina, O; Pieper, CC; Kropp, M; Thumann, G; Erb, C; Karabatsiakis, A; Stetkarova, I; Polivka, J; Costigliola, V. (2022). Ischemic Stroke Of Unclear Aetiology: A Case-By-Case Analysis And Call For A Multi-Professional Predictive, Preventive And Personalised Approach. EPMA Journal, 13(4):535-545. doi:10.1007/s13167-022-00307-z.
34. *Gómez, MG; Castañeda, R; Menduiña, P; Garrido, RU; Markowitz, S. (2013). Estimatingmedical Costs Of Work-Related Diseases In The Basque Country (2008). Medicina Del Lavoro, 104(4):267-276.
35. *Grantham, CE; Hull, KL; Graham-Brown, MPM; March, DS; Burton, JO. (2017). The Potential Cardiovascular Benefıts Of Low-Glucose Degradation Product, Biocompatible Peritoneal Dialysıs Fluids: A Review Of The Literature. Peritoneal Dialysis International,37(4):375-383. doi:10.3747/pdi.2016.00228.
36. *Harmadha, WSP; Muharram, FR; Gaspar, RS; Azimuth, Z; Sulistya, HA; Firmansyah, F; Multazam, CEZ; Harits, M; Putra, RM. (2023). Explaining The Increase Of İncidence And Mortality From Cardiovascular Disease In Indonesia: A global burden of disease study analysis (2000-2019). PLOS ONE,18(12); 10.1371/journal.pone.0294128.
37. *He, QY; Dou, Z; Su, ZH; Shen, HY; Mok, TN; Zhang, CJP; Huang, J; Ming, WK; Li, SJ. (2023). Inpatient Costs Of Congenital Heart Surgery In China: Results From The National Centre For Cardiovascular Diseases. LANCET Regional Health-Western Pacific, 31, 10.1016/j.lanwpc.2022.100623.
38. *Hellebo, A; Kengne, AP; Ademi, Z; Alaba, O. (2024). The Burden of Type 2 Diabetes on the Productivity and Economy in Sub-Saharan Africa: A Life Table Modelling Analysis from a South African Perspective. Pharmacoeconomics, 42(4):463-473. doi:10.1007/s40273-024-01353-3.
39. *Hillis, SD; Mercy, JA; Saul, JR. (2017). The Enduring Impact Of Violence Against Children. Psychology Health & Medicine, 22(4):393-405. doi:10.1080/13548506.2016.1153679.
40. Iqbal, MP (2012). Economic Development By Reducing The Burden Of Cardiovascular Disease in South Asia. Pakistan Journal Of Medical Sciences,28(3):564-566.
41. *Jyani, G; Prinja, S; Ambekar, A; Bahuguna, P; Kumar, R. (2019). Health Impact And Economic Burden Of Alcohol Consumption in India. International Journal Of Drug Policy, 69, 34-42. doi: 10.1016/j.drugpo.2019.04.005.
42. *Kang, HY; Kim, HJ; Park, TK; Jee, SH; Nam, CM; Park, HW. (2003): Economic Burden Of Smoking in Korea. Tobacco Control,12(1):37-44. doi: 10.1136/tc.12.1.37.
43. Karabulut, K. (1999). Sağlık Harcamaları ve Göstergelerinin Karşılaştırılması. Atatürk Üniversitesi İktisadi ve İdari Bilimler Dergisi, 13(1):139-152.
44. *Kontsevaya, AV; Drapkina, OM; Balanova, YA; Imaeva, AE; Suvorova, EI; Khudyakov, MB. (2018). Economic Burden of Cardiovascular Diseases in the Russian Federation in 2016. Rational Pharmacotherapy In Cardiology, 14(2):156-166. doi:10.20996/1819-6446-2018-14-2-156-166.
45. *Kontsevaya, AV; Balanova, YA; Imaeva, AE; Khudyakov, MB; Karpov, OI; Drapkina, OM. (2018). Economic Burden of Hypercholesterolemia in the Russian Federation. Rational Pharmacotherapy In Cardiology,14(3):393- 401. doi: 10.20996/1819-6446-2018-14-3-393-401.
46. *Koronaiou, K; Delipalla, S. (2019). The Economic Cost Of Tobacco Smoking And Secondhand Smoke In Greece: Musculoskeletal Disorders The Leading Contributor To Smoking Related Morbidity. Tobacco Preventıon & Cessatıon, 5, 10.18332/tpc/113091.
47. *Koronaiou, K; Al-Lawati, JA; Sayed, M; Alwadey, AM; Alalawi, EF; Almutawaa, K; Hussain, AH; Al-Maidoor, W; Al-Farsi, YM; Delipalla, S. (2021). Economic Cost Of Smoking And Secondhand Smoke Exposure In The Gulf Cooperation Council Countries. Tobacco Control, 30(6): 680-686. http://dx.doi.org/10.1136/tobaccocontrol-2020-055715.
48. *Larsen, B; Sánchez-Triana, E.(2023). Global Health Burden And Cost Of Lead Exposure In Children And Adults: A Health Impact And Economic Modelling Analysis. Lancet Planetary Health,7(10):E831-E840. doi:10.1016/S2542-5196(23)00166-3.
49. *Li, C; Chen, KY; Cornelius, V; Tomeny, E; Wang, Y; Yang, XW; Yuan, XD; Qin, R; Yu, DH; Wu, ZQ; Wang, DL; Chen, T. (2021). Applicability And Cost-Effectiveness Of The Systolic Blood Pressure Intervention Trial (SPRINT) In The Chinese Population: A Cost-Effectiveness Modeling Study. PLOS Medicine, 18(3), 10.1371/journal.pmed.1003515.
50. *Li, XZ; Li, YJ; Yu, B; Zhu, HW; Zhou, ZL; Yang, Y; Liu, SJ; Tian, YY; Xiao, JJ; Xing, XY; Yin, L. (2022). Health And Economic İmpacts Of Ambient Air Pollution On Hospital Admissions For Overall And Specific Cardiovascular Diseases in Panzhihua, Southwestern China. Journal Of Global Health, 12, 10.7189/jogh.12.11012.
51. Lin, JK; Moran, AE; Bibbins-Domingo, K; Falase, B; Tobias, AP; Mandke, CN; Kazi, DS.(2019). Cost-effectiveness Of A Fixed-Dose Combination Pill For Secondary Prevention Of Cardiovascular disease in China, India, Mexico, Nigeria, and South Africa: a modelling study. Lancet Global Health, 7(10):E1346-E1358, doi:10.1016/S2214-109X(19)30339-0.
52. *Liu, DY; Lu, M; Lakshmanan, P; Hu, ZY; Chen, XP. (2021). Increased Provision of Bioavailable Mg through Vegetables Could Significantly Reduce the Growing Health and Economic Burden Caused by Mg Malnutrition. Foods,10(11), 10.3390/foods10112513.
53. *Liu, TY; Tang, ZJ; Cai, C; Wu, N; Jia, J; Yang, G; Zhang, WH. (2023). Cost-effectiveness Analysis Of Digital Therapeutics For Home-Based Cardiac Rehabilitation For Patients With Atrial Fibrillation After Catheter Ablation. Digital Health, 9,10.1177/20552076231211548.
54. *Lukenda, J; Kolaric, B; Kolcic, I; Pazur, V; Biloglav, Z. (2005). Cardiovascular Diseases İn Croatia And Other Transitional Countries: Comparative Study Of Publications, Clinical Interventions, And Burden Of Disease. Croatian Medical Journal, 46(6): 865-874.
55. *Maji, KJ; Arora, M; Dikshit, AK. (2017). Burden Of Disease Attributed To Ambient PM2.5 And PM10 Exposure In 190 cities in China. Environmental Science And Pollution Research, 24(12):11559-11572. doi: 10.1007/s11356-017-8575-7.
56. *Maji, KJ; Ye, WF; Arora, M; Nagendra, SMS. (2018). PM2.5-Related Health And Economic Loss Assessment For 338 Chinese cities. Environment International, 121,392-403. doi:10.1016/j.envint.2018.09.024.
57. *Manyazewal, T; Ali, MK; Kebede, T; Magee, MJ; Getinet, T; Patel, SA; Hailemariam, D; Escoffery, C; Woldeamanuel, Y; Makonnen, N; Solomon, S; Amogne, W; Marconi, VC; Fekadu, A. (2023). Mapping Digital Health Ecosystems In Africa In The Context Of Endemic Infectious And Non-Communicable Diseases. NPJ Digital Medicine, 6(1), 10.1038/s41746-023-00839-2.
58. *Markovic, D; Lukenda, J; Kokic, V; Simac, P; Zivkovic, PM; Prkacin, I; Culic, V. (2021). A Ten-Year Comparative Study Of Cardiovascular Disease Publications, Health And Socioeconomic İndicators Between European Countries. Signa Vitae, 17(3):95-102. doi:10.22514/sv.2021.053.
59. *Mehrmal, S; Uppal, P; Nedley, N; Giesey, RL; Delost, GR. (2021). The Global, Regional, And National Burden Of Psoriasis In 195 Countries And Territories, 1990 to 2017: A systematic analysis from the Global Burden of Disease Study 2017. Journal Of The American Academy Of Dermatology,84(1):46-52. doi: 10.1016/j.jaad.2020.04.139.
60. *Minh, HV; Huong, DL; Giang, KB; Byass, P. (2009). Economic Aspects Of Chronic Diseases İn Vietnam. Global Health Action, 2, 10.3402/gha.v2i0.1965.
61. Muka, T; Imo, D; Jaspers, L; Colpani, V; Chaker, L; van der Lee, SJ; Mendis, S; Chowdhury, R; Bramer, WM; Falla, A; Pazoki, R; Franco, OH. (2015). The Global Impact Of Non-Communicable Diseases On Healthcare Spending And National Income: A Systematic Review. European Journal Of Epidemiology, 30(4):251-277. doi: 10.1007/s10654-014-9984-2
62. Ngalesoni, F; Ruhago, G; Mayige, M; Oliveira, TC; Robberstad, B; Norheim, OF; Higashi, H. (2017). Cost-effectiveness Analysis Of Population-Based Tobacco Control Strategies In The Prevention Of Cardiovascular Diseases İn Tanzania. PLOS ONE, 12(8), 10.1371/journal.pone.0182113.
63. *Nguyen-Thi, HY; Le-Phuoc, TN; Phat, NT; Van, DT; Le-Thi, TT; Le, NDT; Tran-Thi, HN; Dinh, LP (2021). The Economic Burden of Chronic Kidney Disease in Vietnam. Health Services Insights,14,doi: 10.1177/11786329211036011.
64. *Oganov, RG, Kontsevaya, AV, Kalinina, AM.(2011). Economic Burden Of Cardiovascular Disease In The Russian Federation. Cardiovascular Therapy And Prevention, 10(4):4-9.
65. *Oggioni, C; Lara, J; Wells, JCK; Soroka, K; Siervo, M. (2014). Shifts In Population Dietary Patterns And Physical İnactivity As Determinants Of Global Trends In The Prevalence Of Diabetes: An Ecological Analysis. Nutrition Metabolism And Cardiovascular Diseases, 24(10):1105-1111. doi:10.1016/j.numecd.2014.05.005.
66. *Oggioni, C; Cena, H; Wells, JCK; Lara, J; Celis-Morales, C; Siervo, M. (2015). Association Between Worldwide Dietary And Lifestyle Patterns With Total Cholesterol Concentrations And Dalys For İnfectious And Cardiovascular Diseases: An Ecological Analysis. Journal Of Epidemiology And Global Health, 5(4): 315-325. doi: 10.1016/j.jegh.2015.02.002.
67. *Pallari, E; Lewison, G; Pallari, CT; Samoutis, G; Begum, M; Sullivan, R. (2018). The Contribution Of Cyprus To Non-Communicable Diseases And Biomedical Research From 2002 To 2013: Implications For Evidence-Based Health Policy. Health Research Policy And Systems, 16, 10.1186/s12961-018-0355-4.
68. *Paratz, ED; Smith, K; Ball, J; van Heusden, A; Zentner, D; Parsons, S; Morgan, N; Thompson, T; James, P; Pflaumer, A; Semsarian, C; Stub, D; Liew, D; La Gerche, A. (2021). The Economic Impact Of Sudden Cardiac Arrest. Resuscitation, 163,49-56. doi: 10.1016/j.resuscitation.2021.04.001.
69. *Pichon-Riviere, A; Bardach, A; Augustovski, F; Alcaraz, A; Reynales-Shigematsu, LM; Pinto, MT; Castillo-Riquelme, M; Torres, EP; Osorio, DI; Huayanay, L; Munarriz, CL; de Miera-Juárez, BS; Gallegos-Rivero, V; De La Puente, C; Navia-Bueno, MD; Caporale, J. (2016). Financial Impact Of Smoking On Health Systems In Latin America:A Study Of Seven Countries And Extrapolation To The Regional Level. Revista Panamericana De Salud Publica-Pan American Journal Of Public Health, 40(4):213-221.
70. *Schofield, D; Shrestha, R; Percival, R; Passey, M; Callander, E; Kelly, S. (2013). The Personal And National Costs Of CVD: Impacts On İncome, Taxes, Government Support Payments And GDP Due To Lost Labour Force Participation. International Journal Of Cardiology,166(1):68-71. doi: 10.1016/j.ijcard.2011.09.066.
71. *Siqueira, ADE; de Siqueira, AG; Land, MGP. (2017). Analysis of the Economic Impact of Cardiovascular Diseases in the Last Five Years in Brazil. Arquıvos Brasileiros De Cardiologia, 109(1): 39-46. doi: 10.5935/abc.20170068.
72. *Schofield, D; Cunich, M; Shrestha, R; Passey, M; Veerman, L; Tanton, R; Kelly, S. (2019). The Indirect Costs Of Ischemic Heart Disease Through Lost Productive Life Years For Australia From 2015 to 2030: Results From A Microsimulation Model. BMC Public Health, 19,10.1186/s12889-019-7086-5.
73. *Seuring, T; Archangelidi, O; Suhrcke, M. (2015). The Economic Costs of Type 2 Diabetes: A Global Systematic Review. Pharmacoeconomics, 33(8):811-831. doi:10.1007/s40273-015-0268-9.
74. *Siskind, D; Baingana, F; Kim, J. (2008). Cost-effectiveness Of Group Psychotherapy For Depression In Uganda. Journal Of Mental Health Policy And Economics, 11(3):127-133.
75. *Siskind, D; Araya, R; Kim, J. (2010). Cost-effectiveness Of İmproved Primary Care Treatment Of Depression In Women in Chile. British Journal Of Psychiatry, 197(4): 291-296. doi: 10.1192/bjp.bp.109.068957.
76. *Soares, GP; Brum, JD; de Oliveira, GMM; Klein, CH; Silva, NASE (2013). Evolution of Socioeconomic Indicators and Cardiovascular Mortality in Three Brazilian States. Arquivos Brasıleiros De Cardiologia, 100(2)147-155. doi:10.5935/abc.20130028.
77. Suhrcke M, Urban D (2010). Are Cardiovascular Diseases Bad For Economic Growth? Health Econ,19(12):1478-1496.doi.org/10.1002/hec.1565.
78. *Tang, K; Zhang, Y; Wang, HY; Tan, SH; Bai, L; Liu, YN. (2020). Regional Economic Development, Household Income, Gender And Hypertension: Evidence From Half A Million Chinese. BMC Public Health,20(1),10.1186/s12889-020-09002-y
79. *Tang, XW; Zhan, ZY; Rao, ZX; Fang, HY; Jiang, J; Hu, XJ; Hu, ZJ. (2023). A Spatiotemporal Analysis Of The Association Between Carbon Productivity, Socioeconomics, Medical Resources And Cardiovascular Diseases In Southeast Rural China. Frontıers In Public Health, 11, 10.3389/fpubh.2023.1079702.
80. *Tomoike, H; Yokoyama, H; Sumita, Y; Hanai, S; Kada, A; Okamura, T; Yoshikawa, J; Doi, Y; Hori, M; Tei, C. (2015). Nationwide Distribution of Cardiovascular Practice in Japan - Results of Japanese Circulation Society 2010 Annual Survey. Circulation Journal, 79(5):1058-1067. doi:10.1253/circj.CJ-14-1214.
81. *Yao, MH; Wu, GH; Zhao, X; Zhang, JY. (2020). Estimating Health Burden And Economic Loss Attributable To Short-Term Exposure To Multiple Air Pollutants İn China. Envıronmental Research, 183, 10.1016/j.envres.2020.109184.
82. Yousefi, M; Dastan, I; Alinezhad, F; Ranjbar, M; Hamelmann, C; Ostovar, A; Moghisi, A; Mohammadi, S; Mataria, A; Hammerich, A; Slama, S; Pourghazian, N; Hezaveh, AM; Valizadeh, B; Torabi, P; Najmi, M; Moradi, M; Hodjatzadeh, A; Keshvari-Shad, F. (2022). Prevention And Control Of Non Communicable Diseases In Iran: The Case For Investment. BMC Public Health, 22(1), 10.1186/s12889-022-13615-w.
83. Wan, Y; Yang, HW; Masui, T. (2005). Health And Economic İmpacts Of Air Pollution İn China: A Comparison Of The General Equilibrium Approach And Human Capital Approach. Biomedical And Environmental Sciences, 18(6):427-441.
84. *Wang, Y; Li, J; Wang, LJ; Lin, Y; Zhou, MG; Yin, P; Yao, SL. (2021). The Impact Of Carbon Monoxide On Years Of Life Lost And Modified Effect By İndividual- And City-Level Characteristics: Evidence From A Nationwide Time-Series Study in China. Ecotoxicology And Environmental Safety, 210, 10.1016/j.ecoenv.2020.111884.
85. *Wang, W; Zhang, M; Xu, CD; Ye, PP; Liu, YN; Huang, ZJ; Hu, CH; Zhang, X; Zhao, ZP; Li, C; Chen, XR; Wang, LM; Zhou, MG. (2021). Hypertension Prevalence, Awareness, Treatment, and Control and Their Associated Socioeconomic Factors in China: A Spatial Analysis of A National Representative Survey. Biomedical And Environmental Sciences, 34(12): 937+, 10.3967/bes2021.130.
86. *Win, ZM; Mao, WH; Traill, T; Kyaw, ZL; Paing, PY; Ogbuoji, O; Yamey, G. (2024). Cost-effectiveness And Budget Impact Analysis Of Screening And Preventive İnterventions For Cardiovascular Disease In Myanmar: An Economic Modelling Study. LANCET Regional Health - Southeast Asia, 26, 10.1016/j.lansea.2024.100394.
87. *Xu, R; Han, QF; Zhu, TY; Ren, YP; Chen, JH; Zhao, HP; Chen, MH; Dong, J; Wang, Y; Hao, CM; Zhang, R; Zhang, XH; Wang, M; Tian, N; Wang, HY.(2012). Impact of Individual and Environmental Socioeconomic Status on Peritoneal Dialysis Outcomes: A Retrospective Multicenter Cohort Study. PLOS ONE, 7(11),10.1371/journal.pone.0050766.
88. *Zahra, A; Lee, EW; Sun, LY; Park, JH. (2015). Cardiovascular Disease And Diabetes Mortality, And Their Relation To Socio-Economical, Environmental, And Health Behavioural Factors In Worldwide View. Public Health, 129(4):385-395. doi: 10.1016/j.puhe.2015.01.013.
89. *Zhang, XY; Lu, JP; Wu, CQ; Cui, JL; Wu, Y; Hu, AN; Li, J; Li, X. (2021). Healthy Lifestyle Behaviours And All-Cause And Cardiovascular Mortality Among 0.9 Million Chinese Adults. International Journal Of Behavioral Nutritıon And Physical Activity,18(1), 10.1186/s12966-021-01234-4.
90. *Zhang, TT; Liang, ZR; Lin, TF; Cohen, DJ; Arrieta, A; Wang, XB; Qin, XH; Wang, BY; Huo, Y; Liu, GG; Jiang, J; Zhang, ZG. (2022). Cost-effectiveness Of Folic Acid Therapy For Primary Prevention Of Stroke In Patients With Hypertension. BMC Medicine, 20(1) 10.1186/s12916-022-02601-z.
91. *Zhang, XM; Pan, TX; McPake, B. (2023). -Examining The Reversal Hypothesis: A Nationwide Population-Based Study Of The Association Between Socioeconomic Status, And Ncds And Risk Factors In China. SSM-Populatıon Health, 21, 10.1016/j.ssmph.2022.101335
92. Zhong, YL; Guo, Y; Liu, DM; Zhang, QT; Wang, LZ. (2024). Spatiotemporal Patterns and Equity Analysis of Premature Mortality Due to Ischemic Heart Disease Attributable to PM2.5 Exposure in China: 2007-2022. Toxics, 12(9), 10.3390/toxics12090641.
93. https://www.webofscience.com